FDAnews Drug Daily Bulletin

ALLERGAN OFFERS $3.2 BLN FOR INAMED, TOPPING MEDICIS

Nov. 16, 2005
A A

Allergan Inc., the maker of the Botox wrinkle treatment, offered $3.2 billion in cash and shares for U.S. breast implant maker Inamed Corp., topping a bid by Medicis Pharmaceutical Corp. Investors in Inamed will get $84 for each of their shares, which is about 16 percent more than the current value of Medicis' offer, the Irvine, California-based Allergan said today in a Business Wire statement. Allergan's bid is 13 percent more than Inamed's closing share price yesterday.

Bloomberg (http://quote.bloomberg.com/apps/news?pid=10000006&sid=aUZkTriCyLMA&refer=home)